Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 11:9:199-203.
doi: 10.2147/MDER.S102146. eCollection 2016.

Pulse oximetry screening: a review of diagnosing critical congenital heart disease in newborns

Melissa S Engel  1 , Lazaros K Kochilas  2
Affiliations
Review

Pulse oximetry screening: a review of diagnosing critical congenital heart disease in newborns

Melissa S Engel et al. Med Devices (Auckl). .

Abstract

Congenital heart disease (CHD) is one of the most common birth defects, with an incidence of nine out of every 1,000 live births. The mortality of infants with CHD has decreased over the past 3 decades, but significant morbidity and mortality continue to occur if not diagnosed shortly after birth. Pulse oximetry was recommended as a screening tool to detect critical CHD in 2011 by the American Academy of Pediatrics and the American Heart Association. Pulse oximetry is a tool to measure oxygen saturation, and based on the presence of hypoxemia, many cardiac lesions are detected. Due to its ease of application to the patient, providing results in a timely manner and without the need for calibrating the sensor probe, pulse oximetry offers many advantages as a screening tool. However, pulse oximetry has also important limitations of which physicians should be aware to be able to assess the significance of the pulse oximetry measurement for a given patient. This review aims to highlight the benefits and shortcomings of pulse oximetry within the context of screening for critical CHD and suggests future avenues to cover existing gaps in current practices.

Keywords: congenital heart disease; critical congenital heart disease; newborn; newborn screening; pulse oximetry.

PubMed Disclaimer

References

    1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900. - PubMed
    1. Mahle WT, Newburger JW, Matherne GP, et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young. Council on Cardiovascular Nursing; Interdisciplinary Council on Quality of Care and Outcomes Research. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Committee on Fetus and Newborn Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation. 2009;120(5):447–458. - PubMed
    1. Schultz AH, Localio AR, Clark BJ, Ravishankar C, Videon N, Kimmel SE. Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics. 2008;121(4):751–757. - PubMed
    1. Ng B, Hokanson J. Missed congenital heart disease in neonates. Congenit Heart Dis. 2010;5(3):292–296. - PubMed
    1. Riehle-Colarusso T, Strickland MJ, Reller MD, et al. Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol. 2007;79(11):743–753. - PubMed

LinkOut - more resources